Inserm Transfert (IT)

<
>
How to read and use this data card.
LOADING...
1717450
3cd0f5c66698422e9efecd546321034d

Lobbying costs:

WARNING: As this organisation lists one or more EP accredited lobbyists, it is highly improbable that its lobbying costs are lower than €10,000.

WARNING: The lobbying costs declared by this organisation are extraordinarily high and may therefore have been over-declared.

1,000,000€ - 1,249,999€

Financial year: 01/01/2019 - 01/12/2019

Lobbyists declared: 17.25 FTE (19)

WARNING: The number of full time equivalent lobbyists declared by this organisation are extraordinarily high and may therefore have been over-declared.

10
5
1
1
0.25

Lobbyists with EP accreditation: 0

Meetings with European Commission: 0

Lobbying costs over the years:

1
5
10
100
1000

Inserm Transfert (IT)

Registration on EU Transparency Register

190044226228-01 (First registered: 22 Mar 2017)

Goals / Remit

Private subsidiary of Inserm, Inserm Transfert manages every aspect of the promotion and transfer of knowledge obtained by Inserm’s research laboratories to industry, thereby helping to promote health innovation. Inserm Transfert focus on adding value and minimizing risk for innovative projects at pre-industrial stage, bridging discovery and clinical research. We put emphasis on identifying high-potential projects, implementing appropriate proof of concept and IP strategies, and setting up win-win/mutually beneficial industrial partnerships.

Issues

- EU initiatives pertaining to pharmaceutical policy, Research and innovation policy, health policy (both human and animal) - H2020, IMI2 programs, ERC, - Joint action: Health and wellbeing - Horizon Europe: next research and innovation framework programme

Address

Head office:
7 rue de Watt
Paris 75013,
France

Tel: 33 155030100